A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

IsraelRecruitingPHASE3

Conditions

Carcinoma, Non-Small-Cell Lung

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Banner MD Anderson Cancer Center ( Site 0181), Gilbert, Arizona, United States

    Study coordinator · 480-256-6444
  • The University of Arizona Cancer Center - North Campus ( Site 0163), Tucson, Arizona, United States

    Study coordinator · 520-694-2873
  • Providence St. Jude Medical Center ( Site 0106), Fullerton, California, United States

    Study coordinator · 714-446-5900
  • VA Long Beach Healthcare System ( Site 0199), Long Beach, California, United States

    Study coordinator · 562-826-8000
  • USC Norris Comprehensive Cancer Center ( Site 0205), Los Angeles, California, United States

    Study coordinator · 323-865-3000
  • UCSF Medical Center at Mission Bay ( Site 0178), San Francisco, California, United States

    Study coordinator · 877-827-3222
  • University of Colorado Anschutz Medical Campus ( Site 0151), Aurora, Colorado, United States

    Study coordinator · 303-724-9690
  • UCHealth Memorial Hospital Central ( Site 0125), Colorado Springs, Colorado, United States

    Study coordinator · 719-365-5000
  • Banner MD Anderson Cancer Center at North Colorado Medical Center ( Site 0207), Greeley, Colorado, United States

    Study coordinator · 970-810-3894
  • Centura Health - St. Anthony North Health Campus ( Site 0189), Westminster, Colorado, United States

    Study coordinator · 720-627-4840
  • Yale University School of Medicine ( Site 0201), New Haven, Connecticut, United States

    Study coordinator · 203-785-7564
  • Eastern CT Hematology & Oncology Associates ( Site 0202), Norwich, Connecticut, United States

    Study coordinator · 860-886-8362
  • The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156), Fort Lauderdale, Florida, United States

    Study coordinator · 954-771-0692
  • Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami, Florida, United States

    Study coordinator · 786-596-2000
  • Beacon Cancer Care ( Site 0127), Post Falls, Idaho, United States

    Study coordinator · 208-755-2804
  • The University of Chicago Medical Center ( Site 0118), Chicago, Illinois, United States

    Study coordinator · 773-702-2984
  • Maryland Oncology Hematology (MOH) ( Site 8102), Rockville, Maryland, United States

    Study coordinator · 570-808-4772
  • Massachusetts General Hospital ( Site 0136), Boston, Massachusetts, United States

    Study coordinator · 617-724-4000
  • Dana Farber Cancer Hospital ( Site 0155), Boston, Massachusetts, United States

    Study coordinator · 617-632-3000
  • Ellis Fischel Cancer Center ( Site 0133), Columbia, Missouri, United States

  • Lake Regional Hospital-Cancer Center ( Site 0123), Osage Beach, Missouri, United States

  • Roswell Park Cancer Institute ( Site 0184), Buffalo, New York, United States

    Study coordinator · 716-845-3167
  • Hematology-Oncology Associates of CNY ( Site 0164), East Syracuse, New York, United States

    Study coordinator · 315-472-7504
  • The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0216), New York, New York, United States

    Study coordinator · 202-207-2510
  • Icahn School of Medicine at Mount Sinai ( Site 0116), New York, New York, United States

    Study coordinator · 212-523-5559
  • Memorial Sloan Kettering Cancer Center ( Site 0137), New York, New York, United States

    Study coordinator · 212-639-2000
  • SUNY Upstate Cancer Center ( Site 0140), Syracuse, New York, United States

    Study coordinator · 315-464-8237
  • Montefiore Medical Center ( Site 0160), The Bronx, New York, United States

    Study coordinator · 718-405-8404
  • Westchester Medical Center ( Site 0196), Valhalla, New York, United States

    Study coordinator · 914-493-7000
  • Novant Health Weisiger Cancer Insititute ( Site 0266), Charlotte, North Carolina, United States

    Study coordinator · 980-302-6000
  • Novant Health Forsyth Medical Center ( Site 0166), Winston-Salem, North Carolina, United States

    Study coordinator · 336-718-5000
  • University of Cincinnati Medical Center ( Site 0119), Cincinnati, Ohio, United States

    Study coordinator · 513-558-2119
  • St. Lukes Hospital and Health Network ( Site 0186), Bethlehem, Pennsylvania, United States

    Study coordinator · 484-526-7952
  • Thompson Cancer Survival Center ( Site 0168), Knoxville, Tennessee, United States

    Study coordinator · 865-331-1720
  • Elliston Place Medical Oncology & Hematology ( Site 0215), Nashville, Tennessee, United States

    Study coordinator · 615-961-9469
  • Texas Oncology - DFW ( Site 8103), Dallas, Texas, United States

    Study coordinator · 214-370-1987
  • UT Southwestern Medical Center ( Site 0190), Dallas, Texas, United States

    Study coordinator · 903-592-6152
  • Houston Methodist Cancer Center ( Site 0191), Houston, Texas, United States

    Study coordinator · 713-363-8890
  • MD Anderson Cancer Center ( Site 0150), Houston, Texas, United States

    Study coordinator · 713-792-6363
  • Memorial Hermann Cancer Center ( Site 0172), Houston, Texas, United States

    Study coordinator · 713-704-3961
  • Michael E. DeBakey VA Medical Center ( Site 0197), Houston, Texas, United States

    Study coordinator · 713-873-200
  • O'Quinn Medical Tower at McNair Campus ( Site 0131), Houston, Texas, United States

    Study coordinator · 832-957-6500
  • The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0148), Tyler, Texas, United States

    Study coordinator · 903-592-6152
  • Virginia Cancer Specialists ( Site 0167), Fairfax, Virginia, United States

    Study coordinator · 571-350-8400
  • Virginia Oncology Associates (VOA) ( Site 8101), Norfolk, Virginia, United States

    Study coordinator · 757-466-8683
  • VCU Health Adult Outpatient Pavillion ( Site 0193), Richmond, Virginia, United States

    Study coordinator · 804-828-7999
  • Swedish Cancer Institute ( Site 0143), Seattle, Washington, United States

    Study coordinator · 855-922-6237
  • Virginia Mason Franciscan Health - St. Michael Cancer Center ( Site 0192), Silverdale, Washington, United States

    Study coordinator · 564-240-3100
  • CEMIC ( Site 2454), Caba., Buenos Aires, Argentina

    Study coordinator · 5411529901002543
  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2459), Ciudad Autonoma de Buenos Aires., Buenos Aires, Argentina

    Study coordinator · 49590200
  • Fundacion Intecnus ( Site 2456), Bariloche, Río Negro Province, Argentina

    Study coordinator · 0294154293757
  • Centro Médico IPAM ( Site 2452), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414858585
  • Instituto Medico Especializado Alexander Fleming ( Site 2457), Buenos Aires, Argentina

    Study coordinator · +541132218900
  • Instituto Oncologico de Cordoba -IONC ( Site 2455), Córdoba, Argentina

    Study coordinator · 5493516165267
  • Calvary Mater Newcastle ( Site 2106), Waratah, New South Wales, Australia

    Study coordinator · 61240143584
  • Tasman Oncology Research ( Site 2104), Southport, Queensland, Australia

  • Princess Alexandra Hospital ( Site 2102), Woolloongabba, Queensland, Australia

    Study coordinator · 0061731763515
  • Grampians Health ( Site 2101), Ballarat, Victoria, Australia

    Study coordinator · 61(03)53208500
  • One Clinical Research ( Site 2103), Nedlands, Western Australia, Australia

    Study coordinator · 0061862799466
  • Cliniques Universitaires Saint-Luc ( Site 1203), Brussels, Bruxelles-Capitale, Region de, Belgium

    Study coordinator · +32.2.764.79.25
  • Jessa Ziekenhuis ( Site 1204), Hasselt, Limburg, Belgium

    Study coordinator · +32 11 33 50 23
  • UZ Gent ( Site 1201), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +32 9 332 59 11
  • CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 2502), Fortaleza, Ceará, Brazil

    Study coordinator · +5585991372979
  • Liga Norte Riograndense Contra o Cancer ( Site 2513), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +558440095595
  • Hospital Tacchini ( Site 2506), Bento Gonçalves, Rio Grande do Sul, Brazil

    Study coordinator · 555434554333x1125
  • Hospital de Clínicas de Passo Fundo ( Site 2504), Passo Fundo, Rio Grande do Sul, Brazil

    Study coordinator · +555421033490
  • Hospital Moinhos de Vento ( Site 2510), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +55 51 99604-4976
  • Hospital Nossa Senhora Da Conceicao ( Site 2512), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133572092
  • Instituto de Oncologia Saint Gallen ( Site 2507), Santa Cruz do Sul, Rio Grande do Sul, Brazil

    Study coordinator · +555130568686
  • Hospital de Amor - Barretos ( Site 2511), Barretos, São Paulo, Brazil

    Study coordinator · +551733216638
  • Instituto Nacional de Câncer - INCA ( Site 2501), Rio de Janeiro, Brazil

    Study coordinator · +552132076564
  • MBAL Uni Hospital ( Site 1253), Panagyurishte, Pazardzhik, Bulgaria

    Study coordinator · +35935788581
  • MHAT - Heart and Brain ( Site 1252), Pleven, Bulgaria

    Study coordinator · +35964678400
  • Queen Elizabeth II Health Sciences Centre ( Site 1101), Halifax, Nova Scotia, Canada

    Study coordinator · 9024738317
  • Hamilton Health Sciences - Juravinski Site ( Site 1104), Hamilton, Ontario, Canada

    Study coordinator · 9053879495
  • Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 1105), Kingston, Ontario, Canada

    Study coordinator · 6135496666
  • Lakeridge Health ( Site 1107), Oshawa, Ontario, Canada

    Study coordinator · 905-576-8711x32802
  • Sunnybrook Research Institute ( Site 1106), Toronto, Ontario, Canada

    Study coordinator · 4164806100
  • McGill University Health Centre ( Site 1103), Montreal, Quebec, Canada

    Study coordinator · 5149341934
  • IUCPQ ( Site 1112), Québec, Quebec, Canada

    Study coordinator · 4186568711
  • Orlandi Oncologia ( Site 2555), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56226057491
  • FALP ( Site 2551), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56224205098
  • Clínica RedSalud Vitacura ( Site 2556), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56223954044
  • Bradfordhill ( Site 2552), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56229490970
  • ONCOCENTRO APYS ( Site 2554), Viña del Mar, Valparaiso, Chile

    Study coordinator · 56323320850
  • Bradford Hill Norte ( Site 2563), Antofagasta, Chile

    Study coordinator · +56552655924
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 2603), Bogotá, Bogota D.C., Colombia

    Study coordinator · +573016348173
  • Hospital Universitario San Ignacio ( Site 2610), Bogotá, Bogota D.C., Colombia

    Study coordinator · 573108658288
  • Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 2604), Bogotá, Bogota D.C., Colombia

    Study coordinator · 573103130894
  • IMAT S.A.S ( Site 2602), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +573135342052
  • Oncologos del Occidente ( Site 2608), Pereira, Risaralda Department, Colombia

    Study coordinator · +573187715522
  • Fundacion Valle del Lili- CIC ( Site 2601), Cali, Valle del Cauca Department, Colombia

  • Oulun yliopistollinen sairaala ( Site 1301), Oulu, Northern Savonia, Finland

    Study coordinator · +35883153789
  • Turku University Hospital ( Site 1303), Turku, Southwest Finland, Finland

    Study coordinator · +35823138709
  • Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau ( Site 1354), Tours, Centre-Val de Loire, France

    Study coordinator · 33247478701
  • CHU Besançon ( Site 1358), Besançon, Franche-Comte, France

  • Institut De Cancerologie De L Ouest ( Site 1357), Saint-Herblain, Loire-Atlantique, France

    Study coordinator · +33240679900
  • Institut Cœur Poumon -CHU Lille ( Site 1352), Lille, Nord, France

    Study coordinator · +333.20.44.59.62
  • CENTRE LEON BERARD ( Site 1351), Lyon, Rhone, France

    Study coordinator · +33478782828
  • Pitie Salpetriere University Hospital ( Site 1355), Paris, France

    Study coordinator · 33142160508
  • Gustave Roussy ( Site 1353), Villejuif, Île-de-France Region, France

    Study coordinator · + 33 1 42 11 67 78
  • Thoraxklinik-Heidelberg gGmbH ( Site 1412), Heidelberg, Baden-Wurttemberg, Germany

    Study coordinator · +4962213961350
  • Robert-Bosch-Krankenhaus ( Site 1401), Stuttgart, Baden-Wurttemberg, Germany

    Study coordinator · 0049 711 8101-7757
  • Klinikverbund Allgäu gGmbH ( Site 1408), Kempten (Allgäu), Bavaria, Germany

    Study coordinator · +49 0831 530 1934
  • UKGM Gießen/Marburg ( Site 1404), Giessen, Hesse, Germany

    Study coordinator · 004964198543591
  • Pius Hospital Oldenburg ( Site 1407), Oldenburg, Lower Saxony, Germany

    Study coordinator · +494412291611
  • St.-Antonius-Hospital ( Site 1411), Eschweiler, North Rhine-Westphalia, Germany

    Study coordinator · 0049 2403-761737
  • Universitätsklinikum Münster - Albert Schweitzer Campus ( Site 1405), Münster, North Rhine-Westphalia, Germany

    Study coordinator · +49 251 83-52712
  • Marienhaus Klinikum Mainz ( Site 1403), Mainz, Rhineland-Palatinate, Germany

    Study coordinator · 0049 6131/57583 2406
  • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1452), Pátrai, Achaia, Greece

    Study coordinator · 0030 2613603791
  • Errikos Dunant Hospital Center ( Site 1457), Athens, Attica, Greece

    Study coordinator · 0030 2106972246
  • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1451), Athens, Attica, Greece

    Study coordinator · 0030 2107700220
  • Metropolitan Hospital ( Site 1459), Athens, Attica, Greece

    Study coordinator · 0030 2104807106
  • ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1460), Chaïdári, Attica, Greece

    Study coordinator · 0030 2313301848
  • University General Hospital of Herakleion ( Site 1458), Heraklion, Irakleio, Greece

    Study coordinator · 0030 2810392091
  • University General Hospital of Larissa-Oncology Clinic ( Site 1453), Larissa, Thessaly, Greece

    Study coordinator · 0030 2413501636
  • Papageorgiou General Hospital of Thessaloniki ( Site 1454), Thessaloniki, Greece

    Study coordinator · 0030 2313323867
  • Fejér Megyei Szent György Egyetemi Oktató Kórház ( Site 1506), Székesfehérvár, Fejér, Hungary

    Study coordinator · (06 22) 535 500
  • Petz Aladár Megyei Oktató Kórház ( Site 1502), Győr, Győr-Moson-Sopron, Hungary

    Study coordinator · +36704454354
  • Debreceni Egyetem Altalanos Orvostudomanyi Kar Tudogyogyaszati Tanszek ( Site 1508), Debrecen, Hajdú-Bihar, Hungary

    Study coordinator · 0652255222
  • Mátrai Gyógyintézet ( Site 1504), Mátraháza, Heves County, Hungary

    Study coordinator · +36 37 574 500
  • Reformatus Pulmonologiai Centrum-Onkopulmonologiai Jarobeteg Centrum ( Site 1505), Törökbálint, Pest County, Hungary

    Study coordinator · +36307005601
  • Somogy Vármegyei Kaposi Mór Oktató Kórház-Oncology center ( Site 1507), Kaposvár, Somogy County, Hungary

    Study coordinator · +3682501300/1669
  • Orszagos Koranyi Pulmonologiai Intezet ( Site 1501), Budapest, Hungary

    Study coordinator · +3613913213
  • Cork University Hospital ( Site 1553), Cork, Ireland

    Study coordinator · 00353214922603
  • St. James's Hospital ( Site 1554), Dublin, Ireland

    Study coordinator · 0035314103747
  • Tallaght University Hospital ( Site 1551), Dublin, Ireland

    Study coordinator · 0035314144209
  • Rambam Health Care Campus ( Site 1603), Haifa, Israel

    Study coordinator · +97247772688
  • Shaare Zedek Medical Center ( Site 1601), Jerusalem, Israel

    Study coordinator · +97226666666
  • Hadassah Medical Center ( Site 1605), Jerusalem, Israel

    Study coordinator · +97226777333
  • Meir Medical Center ( Site 1606), Kfar Saba, Israel

    Study coordinator · +97297472555
  • Sheba Medical Center ( Site 1602), Ramat Gan, Israel

    Study coordinator · +972-35307032
  • AOU Renato Dulbecco ( Site 1661), Catanzaro, Calabria, Italy

    Study coordinator · 390961883771
  • Ospedale Santa Maria delle Croci ( Site 1652), Ravenna, Emilia-Romagna, Italy

    Study coordinator · 00390544285247
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1653), Rome, Lazio, Italy

    Study coordinator · +390630154277
  • Fondazione Policlinico Universitario Campus Bio-Medico ( Site 1660), Rome, Roma, Italy

    Study coordinator · +3906225411160
  • Istituto Nazionale Tumori Regina Elena ( Site 1651), Rome, Roma, Italy

    Study coordinator · 00390652666779
  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1656), Milan, Italy

    Study coordinator · +390223903829
  • IEO Istituto Europeo di Oncologia ( Site 1655), Milan, Italy

    Study coordinator · 00390257489482
  • Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1657), Naples, Italy

    Study coordinator · 00390817770291
  • IRCCS Istituto Oncologico Veneto ( Site 1654), Padova, Italy

    Study coordinator · +390498215608
  • Centro Ricerche Cliniche di Verona ( Site 1659), Verona, Italy

    Study coordinator · +390458128124
  • Hospital of the University of Occupational and Environmental Health, Japan ( Site 1166), Kitakyushu, Fukuoka, Japan

    Study coordinator · +81-93-603-1611
  • St. Marianna University Hospital ( Site 1159), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Kanagawa Cancer Center ( Site 1158), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Kindai University Hospital ( Site 1162), Sakai, Osaka, Japan

    Study coordinator · +81-72-288-7222
  • Shizuoka Cancer Center ( Site 1160), Sunto-gun, Shizuoka, Japan

    Study coordinator · +81-55-989-5222
  • Dokkyo Medical University Hospital ( Site 1152), Shimotsuga-gun, Tochigi, Japan

    Study coordinator · +81-282-86-1111
  • National Cancer Center Hospital ( Site 1156), Chūō, Tokyo, Japan

    Study coordinator · +81-3-3542-2511
  • Tokyo Medical University Hospital ( Site 1157), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • Chiba University Hospital ( Site 1154), Chiba, Japan

    Study coordinator · +81-43-226-2616
  • National Hospital Organization Kyushu Cancer Center ( Site 1167), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Fukushima Medical University Hospital ( Site 1151), Fukushima, Japan

    Study coordinator · +81-24-547-1111
  • Hiroshima University Hospital ( Site 1165), Hiroshima, Japan

    Study coordinator · +81-82-257-5555
  • Okayama University Hospital ( Site 1164), Okayama, Japan

    Study coordinator · +81-86-235-7991
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1161), Osaka, Japan

    Study coordinator · +81-6-6945-1181
  • Wakayama Medical University Hospital ( Site 1163), Wakayama, Japan

    Study coordinator · +81-73-447-2300
  • Radboudumc ( Site 1706), Nijmegen, Gelderland, Netherlands

    Study coordinator · +31 (0)24 3610325
  • Maastricht UMC+ ( Site 1705), Maastricht, Limburg, Netherlands

    Study coordinator · +31 (0)43 3875047
  • Jeroen Bosch Hospital ( Site 1701), 's-Hertogenbosch, North Brabant, Netherlands

    Study coordinator · +31735532000
  • Medisch Centrum Leeuwarden ( Site 1702), Leeuwarden, Provincie Friesland, Netherlands

    Study coordinator · +31582866666
  • Meander Medisch Centrum ( Site 1703), Amersfoort, Utrecht, Netherlands

    Study coordinator · +31 (0)33 8507843
  • University Medical Center Groningen ( Site 1707), Groningen, Netherlands

    Study coordinator · +31503616161
  • Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site 2201), Tauranga, Bay of Plenty, New Zealand

    Study coordinator · +6475798153
  • Dunedin Hospital ( Site 2202), Dunedin, Otago, New Zealand

    Study coordinator · +6434740999
  • Waikato Hospital ( Site 2204), Hamilton, Waikato Region, New Zealand

    Study coordinator · +6478398976
  • Aliada ( Site 2753), Lima, Peru

    Study coordinator · +51990343323
  • Clínica Internacional - Sede San Borja ( Site 2752), Lima, Peru

    Study coordinator · +5116196161e5563
  • Detecta Clínica ( Site 2751), Lima, Peru

    Study coordinator · +51955575199
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 1763), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48616654203
  • Krakowski Szpital Specjalistyczny im. Jana Pawla II ( Site 1756), Krakow, Lesser Poland Voivodeship, Poland

    Study coordinator · +48663430242
  • Dolnoslaskie Centrum Onkologii Pulmonologii i Hematologii ( Site 1765), Wroclaw, Lower Silesian Voivodeship, Poland

    Study coordinator · 782 999 717
  • Instytut Gruzlicy i Chorob Pluc w Warszawie ( Site 1764), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48224312360
  • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1759), Przemyśl, Podkarpackie Voivodeship, Poland

    Study coordinator · +48166775511
  • Uniwersyteckie Centrum Kliniczne ( Site 1758), Gdansk, Pomeranian Voivodeship, Poland

    Study coordinator · +48583492270
  • Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie ( Site 1760), Olsztyn, Warmian-Masurian Voivodeship, Poland

    Study coordinator · +48895322900
  • Swietokrzyskie Centrum Onkologii. ( Site 1754), Kielce, Świętokrzyskie Voivodeship, Poland

    Study coordinator · +48885997850
  • Centrul Medical Medicover Victoria ( Site 1802), Bucharest, Bucharest, Romania

    Study coordinator · 219896
  • Cabinet Medical Oncomed ( Site 1803), Timișoara, Timiș County, Romania

    Study coordinator · +40256495403
  • S.C. ONCO CARD S.R.L ( Site 1805), Brasov, Romania

    Study coordinator · +40268960
  • Institutul Regional de Oncologie ( Site 1804), Iași, Romania

    Study coordinator · 0374278810
  • National Cancer Centre Singapore ( Site 2251), Singapore, Central Singapore, Singapore

    Study coordinator · +6564368000
  • Tan Tock Seng Hospital ( Site 2252), Singapore, Central Singapore, Singapore

    Study coordinator · +65 6256 6011
  • National Cancer Center ( Site 2305), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · +82-31-920-1694
  • The Catholic University of Korea St. Vincent s Hospital ( Site 2301), Suwon, Kyonggi-do, South Korea

    Study coordinator · +82-31-249-8153
  • Ajou University Hospital ( Site 2306), Suwon, Kyonggi-do, South Korea

    Study coordinator · +82-31-219-5989
  • Seoul National University Hospital ( Site 2303), Seoul, South Korea

    Study coordinator · +82-2-2072-2995
  • Severance Hospital Yonsei University Health System ( Site 2302), Seoul, South Korea

    Study coordinator · +82-2-2228-0880
  • Samsung Medical Center ( Site 2304), Seoul, South Korea

    Study coordinator · +82221489809
  • Seoul St. Mary's Hospital ( Site 2307), Seoul, South Korea

    Study coordinator · +82-2-2258-6045
  • Hospital Insular de Gran Canaria ( Site 1911), Canarias, Canary Islands, Spain

    Study coordinator · +34928441738
  • Complejo Hospitalario Universitario A Coruna ( Site 1916), A Coruña, La Coruna, Spain

    Study coordinator · +34981178000292872
  • Hospital Universitario Quiron Madrid ( Site 1913), Pozuelo de Alarcón, Madrid, Spain

    Study coordinator · +34914521987
  • Hospital Universitari Vall D Hebron ( Site 1910), Barcelona, Spain

    Study coordinator · +34932746000
  • Hospital Clinic de Barcelona ( Site 1919), Barcelona, Spain

    Study coordinator · +34932275402
  • Hospital General Universitario Gregorio Maranon ( Site 1912), Madrid, Spain

    Study coordinator · +34915868115
  • Hospital Quiron Malaga ( Site 1914), Málaga, Spain

    Study coordinator · +34951940000
  • Karolinska Universitetssjukhuset Solna ( Site 1951), Stockholm, Stockholm County, Sweden

    Study coordinator · 46812370000
  • Chung Shan Medical University Hospital ( Site 2351), Taichung, Taiwan

    Study coordinator · +886-4-24739595
  • China Medical University Hospital ( Site 2358), Taichung, Taiwan

    Study coordinator · 886-4-22052121x12626
  • National Cheng Kung University Hospital ( Site 2354), Tainan, Taiwan

    Study coordinator · +88662353535
  • National Taiwan University Cancer Center (NTUCC) ( Site 2360), Taipei, Taiwan

    Study coordinator · +886 2-2322-0322
  • Mackay Memorial Hospital ( Site 2355), Taipei, Taiwan

    Study coordinator · 886-225433535x2854
  • Taipei Medical University Hospital ( Site 2352), Taipei, Taiwan

    Study coordinator · +886227372181
  • Koo Foundation Sun Yat-Sen Cancer Center ( Site 2359), Taipei, Taiwan

    Study coordinator · +886228970011
  • Taipei Veterans General Hospital ( Site 2357), Taipei, Taiwan

    Study coordinator · +886228712121
  • Chang Gung Memorial Hospital ( Site 2361), Taoyuan, Taiwan

    Study coordinator · +886-3-3281200
  • Faculty of Medicine Siriraj Hospital ( Site 2403), Bangkoknoi, Bangkok, Thailand

    Study coordinator · +6624141914
  • Ramathibodi Hospital ( Site 2405), Ratchathewi, Bangkok, Thailand

    Study coordinator · +6622011671
  • Faculty of Medicine - Khon Kaen University ( Site 2401), Muang, Changwat Khon Kaen, Thailand

    Study coordinator · +6643363746
  • Songklanagarind Hospital ( Site 2402), Hat Yai, Changwat Songkhla, Thailand

    Study coordinator · +6674451469
  • Maharaj Nakorn Chiang Mai Hospital ( Site 2404), Muang, Chiang Mai, Thailand

    Study coordinator · +6625790117
  • Hacettepe Universite Hastaneleri ( Site 2001), Sıhhiye, Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 305 50 00
  • Sakarya Universitesi Tip Fakultesi Hastanesi ( Site 2006), Adapazarı, Sakarya, Turkey (Türkiye)

    Study coordinator · +905054785576
  • Namık Kemal University Medical Faculty ( Site 2007), Tekirdağ, Tekirdas, Turkey (Türkiye)

    Study coordinator · +905302073000
  • Adana Medical Park Seyhan Hastanesi ( Site 2010), Adana, Turkey (Türkiye)

    Study coordinator · +905393275092
  • Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Turkey (Türkiye)

    Study coordinator · +903125526000
  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 2003), Istanbul, Turkey (Türkiye)

    Study coordinator · +902166065200
  • Erciyes Universitesi Tıp Fakultesi Hastaneleri ( Site 2009), Kayseri, Turkey (Türkiye)

    Study coordinator · +905388731881
  • Karadeniz Technical University ( Site 2008), Trabzon, Turkey (Türkiye)

    Study coordinator · 04623775200
  • Bristol Haematology and Oncology Centre ( Site 2072), Bristol, Bristol, City of, United Kingdom

    Study coordinator · +441179230000
  • ROYAL MARSDEN HOSPITAL (CHELSEA)-Lung Unit ( Site 2075), London, Kensington and Chelsea, United Kingdom

    Study coordinator · 020 7352 8171
  • St Bartholomews Hospital ( Site 2052), London, London, City of, United Kingdom

    Study coordinator · 00442073777000
  • Royal Free Hospital ( Site 2074), London, London, City of, United Kingdom

    Study coordinator · 0207 794 0500
  • Guys Hospital ( Site 2057), London, London, City of, United Kingdom

    Study coordinator · +442071885050
  • Royal Marsden Hospital (Sutton) ( Site 2076), London, London, City of, United Kingdom

    Study coordinator · 020 8642 6011
  • Nottingham City Hospital ( Site 2058), Nottingham, Nottinghamshire, United Kingdom

    Study coordinator · 00441158231851
  • St James University Hospital ( Site 2055), Leeds, United Kingdom

    Study coordinator · 00441132068225
  • Leicester Royal Infirmary ( Site 2051), Leicester, United Kingdom

    Study coordinator · 00441162585249
  • The Christie NHS Foundation Trust ( Site 2066), Manchester, United Kingdom

    Study coordinator · 00441614463000
  • The Clatterbridge Cancer Centre ( Site 2069), Metropolitan Borough of Wirral, United Kingdom

    Study coordinator · 00441515565000
  • Queen Alexandra Hospital ( Site 2059), Portsmouth, United Kingdom

    Study coordinator · 02392 286000 x4078
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC